Equifax (NYSE:EFX) PT Raised to $333.00

Equifax (NYSE:EFX) had its price objective increased by equities research analysts at Robert W. Baird from $290.00 to $333.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the credit services provider’s stock. Robert W. Baird’s price target points to a potential upside of 18.09% from the stock’s current price.

EFX has been the topic of several other research reports. Oppenheimer upped their target price on Equifax from $300.00 to $315.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. BNP Paribas raised shares of Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective for the company in a research report on Thursday, September 19th. Citigroup lifted their price objective on shares of Equifax from $263.00 to $304.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Barclays increased their target price on shares of Equifax from $300.00 to $380.00 and gave the stock an “overweight” rating in a research note on Friday, September 13th. Finally, Morgan Stanley lifted their price target on shares of Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a research note on Thursday, September 12th. Four analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $310.47.

Equifax Stock Performance

NYSE:EFX opened at $281.99 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.79 and a current ratio of 0.79. Equifax has a fifty-two week low of $159.95 and a fifty-two week high of $309.63. The company has a 50 day simple moving average of $294.95 and a two-hundred day simple moving average of $263.00. The company has a market capitalization of $34.86 billion, a PE ratio of 62.80, a P/E/G ratio of 2.00 and a beta of 1.58.

Equifax (NYSE:EFX) last posted its quarterly earnings data on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.01. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. Equifax had a net margin of 10.67% and a return on equity of 18.88%. Equifax’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.76 earnings per share. Research analysts anticipate that Equifax will post 7.36 earnings per share for the current year.

Insider Activity at Equifax

In other Equifax news, EVP Carla Chaney sold 3,000 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $281.85, for a total value of $845,550.00. Following the completion of the sale, the executive vice president now owns 10,875 shares in the company, valued at approximately $3,065,118.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.57% of the stock is owned by insiders.

Institutional Investors Weigh In On Equifax

Large investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its holdings in Equifax by 72.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,514,093 shares of the credit services provider’s stock worth $405,051,000 after buying an additional 633,887 shares during the last quarter. Capital International Investors grew its holdings in Equifax by 2.5% during the first quarter. Capital International Investors now owns 14,045,398 shares of the credit services provider’s stock valued at $3,757,425,000 after purchasing an additional 342,170 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Equifax by 4.9% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,276,798 shares of the credit services provider’s stock valued at $1,036,952,000 after buying an additional 200,665 shares during the period. Ceredex Value Advisors LLC lifted its position in shares of Equifax by 127.1% during the 2nd quarter. Ceredex Value Advisors LLC now owns 350,356 shares of the credit services provider’s stock valued at $84,947,000 after buying an additional 196,106 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in Equifax by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 14,033,448 shares of the credit services provider’s stock worth $3,754,228,000 after acquiring an additional 137,961 shares during the last quarter. 96.20% of the stock is owned by hedge funds and other institutional investors.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.